Using a special PET scan to guide radiation for brain tumors that spread
Part of Brain & nervous system, Cancer clinical trials.
This study tests a new way of using a PET scan to look at brain tumors that have spread from other cancers, before and after focused radiation treatment. The goal is to see if this scan can better predict how well the radiation works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You need to be in fairly good general health (able to care for yourself).
- You must have at least one brain tumor (or area treated after surgery) that your doctor says can be treated with focused radiation.
- You must be able to have an MRI and a PET scan.
- You cannot be pregnant or nursing, and must use contraception if there's any chance of pregnancy.
- You need to read and write English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special type of brain scan (PET imaging) to better understand how cancer that has spread to the brain responds to radiation treatment. The scan may help doctors see which patients are responding well to treatment.
This trial tests a special PET scan (18F-fluciclovine) to see how well it shows brain metastases after stereotactic radiosurgery (a precise form of radiation). It may help doctors better understand treatment effects.
This trial is for people with cancer that has spread to the brain (brain metastases). It tests a new approach where you start a systemic therapy (drugs that travel through your body) and later add focused radiation to the brain tumors, instead of treating them right away. The goal is to see if this sequence works well and avoids unnecessary side effects.
This study tests a type of radiation treatment for people with one or more brain tumors that are larger than usual (2 to 5 centimeters). It aims to see if this approach is safe and effective, and may be an option if you are not having immediate surgery.
This Phase 1 study tests a form of focused radiation given in stages to shrink larger brain metastases. It may help people whose tumors are in the brain but not suited to whole-brain radiation alone, while also checking safety and how well the treatment can be delivered.
This study tests a more targeted form of stereotactic (precise) brain radiation for people with brain metastases from large cell cancer. It aims to improve the balance between effectiveness and side effects by carefully focusing where the radiation goes.
Hear when a new Brain Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.